We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Provexis Plc | LSE:PXS | London | Ordinary Share | GB00B0923P27 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.675 | 0.60 | 0.75 | - | 0.00 | 11:02:46 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Food Preparations, Nec | 802k | -586k | -0.0003 | -22.33 | 14.97M |
Date | Subject | Author | Discuss |
---|---|---|---|
26/8/2022 04:12 | redprince, "Ian has previously divided his working time between the UK and Australia; in January 2020 Ian returned to live full time in the UK." | gix er | |
25/8/2022 19:25 | It's flagged as XOFF ( not on an exchange ) TNCP ( Transactions not contributing to the price discover trade ) NoR, so is likely to be a transfer from one person to anothsr. So neither a Buy nor a Sell ( edit : But both ) | bareknee | |
25/8/2022 11:46 | 10 mill shares - £78K buy ? | nestoframpers | |
25/8/2022 11:42 | Well the agm is not too far away and i wonder how many pi's will be there to hear the usual cut and paste with a liberal dash of optimistic jam tomorrow thrown in for good meaasure? There is no roadmap,no milestones and no way of being able to measure progress or lack of except the few rns's that we receive. IF is paid much more than his role deserves and it is costing us all in dilution.He has responsibility for overseeing the IP patent protection and for "managing" th relationships with By-Health and DSM.That imo does not deserve the six figure package that he is on and the minimal turnover and complete lack of share price growth over 10 years+ underpin my view. We were originally told By-Health were to have product out by end of 2017.The goal posts just keep getting wider.Conversations with parts of global businesses have been quoted for 10 years or more - not one meaningful deal done. Only on AIM could you hope to get away with such unmerited largesse - is he still in Australia? | redprince | |
22/6/2022 17:03 | I can't really see us investing a massive amount of time and money into growing the FF market that we'll control. DSM, with their sales team, havn't really pulled up any trees in that direction, and I don't think we have any unique expertise in that part of that business to make us feel we could do any better. I expect, well hope, that we'll run the existing customer base as a cash cow while also dealing with the existing pipeline and concentrate more on the ByHealth side of things. As to us being taken over by ByHealth, I can't see that happening in the short to medium term. Putting in place contracts with a supplier ( us ) for Jan 2023 doesn't sound like the sort of thing that ByHealth would do just before making an offer for a company, but wtfdIk ? | bareknee | |
22/6/2022 16:14 | hh - i agree completely on your point regarding developing sales - we would not be able to do that without incurring substantial costs and i do not favour any more dilution. Disagree totally on your seconbd point - also a buyout requires 75% of shareholders to agree and a very substantial amount of shares are held in a relatively small number of hands.Those are imo fairly safe hands who are unlikely to sell early doors. Why would you sell when you do not even know the value of the By-Health deal? 5p atm is wildly optimistic and By-Health would not offer that (initially anyway). Two years down the line from when sales start flowing from their product and 5p may not be unreasonable. Aimvho.Dyor. | redprince | |
22/6/2022 14:26 | The price for buyout from BH has probably already been agreed subject to Blue hat or whatever they are going for now 5p will do me | horridhenry | |
22/6/2022 10:49 | horridhenry - that is a valid point although we still have plenty of cash (over £1 million end March). DSM must not see a whole lot of future in FF and have decided it is not worth further development costs. Two ways of looking at everything i suppose. By-Health are not likely to launch anything for at least another year and possibly longer. Aimho.Dyor. | redprince | |
22/6/2022 09:49 | another cash call then to pay for the new sales department etc. The BH income wont appear for some while yet | horridhenry | |
22/6/2022 09:17 | I don't see a t/o from By-Health on the cards and i certainly hope it isn't.Most people who are hoping for that are doing so because they are fed up waiting for things to get moving here - they will move, starting from next year as we get a much higher cut of the profits under the new deal with DSM. Secondly By-Health has the very real potential to bring in material monies - i do not want any offers for our IP to come in until we know what those monies look like. I haven't invested money in here for 13 years to get taken out on the cheap and investing is for me always a long term game. Hope i am correct. | redprince | |
22/6/2022 07:59 | That's my take on this too..... The future is looking brighter all of a sudden 😀 DL | davidlloyd | |
22/6/2022 07:41 | Something stirring at last? The RNS looks like a tidying up exercise prior to Byhealth T/O ? Can't imagine that we will recruit staff to handle direct sales and pipeline inherited from DSM All very positive i think | horridhenry | |
27/3/2022 12:10 | Lots of w’s In the chart above , looks like it wants to move up ,news needed I think ! | winner31 | |
27/3/2022 08:53 | winner - i think they stopped talking over 10 years ago.CC & Unilever - it was confirmed by at least one board member that one of these two walked away beacuse of lack of exclusivity. DSM have been something of a disappointment - they have not landed a single major in 10 years.Plenty of talk about globals and parts of globals and not a single signing. The only people who have got rich are two of the current BOD.Their rewards were alaways thoroughly unjustifiable imho. | redprince | |
20/3/2022 13:19 | We need a bit of news like this , wonder if they are still talking . | winner31 | |
08/2/2022 14:47 | Could we get a pre-close update this year 31/03/22, please | winner31 | |
30/1/2022 16:53 | Not great volume but something could be brewing . | winner31 | |
08/12/2021 15:06 | Pity this is the wrong seed , | winner31 | |
16/11/2021 18:53 | Thanks RP. I am sure will be rewarded in the end. A verylong journey though | huntergls | |
16/11/2021 18:29 | Hello Huntergis - glad you enjoyed the agm anyway - you always have made the effort to attend.For that you deserve much credit - a genuine holder and one whom i have met. | redprince | |
16/11/2021 11:03 | Looks like mm’s gotta big order to fill and they’re struggling , they will have to raise the bid soon especially if some more buys come in . | winner31 | |
14/11/2021 09:16 | HiRP. Questions were asked. The AGM was positive. Let's see what 2023 brings us. Let's also see what deal we get with DSM. Though I guess due to confidentiality we may not know the full picture. As for the shots product from MM there was no way DSM were going to give them exclusive rights. Far to small a company. Someone/s happy at moment as there is a big buy being filled. All IMO of course | huntergls |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions